Literature DB >> 19455456

Heroin as an attachment substitute? Differences in attachment representations between opioid, ecstasy and cannabis abusers.

Andreas Schindler1, Rainer Thomasius, Kay Petersen, Peter-Michael Sack.   

Abstract

Earlier studies indicated a relation between fearful-avoidant attachment and substance abuse. This study compares attachment representations (Family Attachment Interview; Bartholomew & Horowitz, 1991) of three groups of substance abusers and non-clinical controls. Heroin abusers (N = 22) were mainly fearful-avoidant, ecstasy abusers (N = 31) were preoccupied, fearful-avoidant and dismissing-avoidant, cannabis abusers (N = 19) were mainly dismissing and secure, and controls (N = 22) were mainly secure. Groups did differ in their level of psychosocial functioning (GAF) (cannabis > ecstasy > opioids). Differences in attachment prevailed when GAF was controlled. Based on the self-medication hypothesis we understand the preferences for specific substances to be influenced by specific attachment strategies. Heroin seems to be used as an emotional substitute for lacking coping strategies. Cannabis seems to be used to support existing deactivating and distancing strategies. Ecstasy abuse was related to insecure attachment but not to a specific attachment strategy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455456     DOI: 10.1080/14616730902815009

Source DB:  PubMed          Journal:  Attach Hum Dev        ISSN: 1461-6734


  14 in total

Review 1.  The Influence of Endogenous Opioids on the Relationship between Testosterone and Romantic Bonding.

Authors:  Davide Ponzi; Melissa Dandy
Journal:  Hum Nat       Date:  2019-03

2.  Correlates of substance use severity among homeless youth.

Authors:  Adeline Nyamathi; Angela Hudson; Barbara Greengold; Alexandra Slagle; Mary Marfisee; Farinaz Khalilifard; Barbara Leake
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2010-11

3.  Adult attachment style is associated with cerebral μ-opioid receptor availability in humans.

Authors:  Lauri Nummenmaa; Sandra Manninen; Lauri Tuominen; Jussi Hirvonen; Kari K Kalliokoski; Pirjo Nuutila; Iiro P Jääskeläinen; Riitta Hari; Robin I M Dunbar; Mikko Sams
Journal:  Hum Brain Mapp       Date:  2015-06-05       Impact factor: 5.038

Review 4.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

Review 5.  [Addiction as an attachment disorder].

Authors:  H F Unterrainer; M Hiebler-Ragger; L Rogen; H P Kapfhammer
Journal:  Nervenarzt       Date:  2018-09       Impact factor: 1.214

6.  Exploring the Link among State of Mind Concerning Childhood Attachment, Attachment in Close Relationships, Parental Bonding, and Psychopathological Symptoms in Substance Users.

Authors:  Alessandro Musetti; Grazia Terrone; Paola Corsano; Barbara Magnani; Sergio Salvatore
Journal:  Front Psychol       Date:  2016-08-09

Review 7.  Attachment and Substance Use Disorders-Theoretical Models, Empirical Evidence, and Implications for Treatment.

Authors:  Andreas Schindler
Journal:  Front Psychiatry       Date:  2019-10-15       Impact factor: 4.157

Review 8.  Attachment Theory and Maternal Drug Addiction: The Contribution to Parenting Interventions.

Authors:  Micol Parolin; Alessandra Simonelli
Journal:  Front Psychiatry       Date:  2016-08-30       Impact factor: 4.157

Review 9.  The Role of Attachment in Poly-Drug Use Disorder: An Overview of the Literature, Recent Findings and Clinical Implications.

Authors:  Michaela Hiebler-Ragger; Human-Friedrich Unterrainer
Journal:  Front Psychiatry       Date:  2019-08-27       Impact factor: 4.157

10.  Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa.

Authors:  Andrew Scheibe; Shaun Shelly; Tara Gerardy; Zara von Homeyer; Andrea Schneider; Kalvanya Padayachee; Shalon Balaguru Naidoo; Klaas Mtshweni; Ayanda Matau; Harry Hausler; Monique Marks
Journal:  Addict Sci Clin Pract       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.